Sabra Healthcare REIT, Inc. $SBRA Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 1,019.8% during the fourth quarter, Holdings Channel reports. The firm owned 3,005,374 shares of the real estate investment trust’s stock after acquiring an additional 2,736,993 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Sabra Healthcare REIT were worth $56,922,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Cornerstone Wealth Management LLC increased its holdings in shares of Sabra Healthcare REIT by 256.6% in the third quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after purchasing an additional 28,625 shares during the period. AlphaQuest LLC boosted its stake in shares of Sabra Healthcare REIT by 309.2% in the third quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock worth $2,700,000 after buying an additional 109,444 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al boosted its stake in shares of Sabra Healthcare REIT by 51.2% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock worth $10,770,000 after buying an additional 195,600 shares during the last quarter. Allianz Asset Management GmbH boosted its stake in shares of Sabra Healthcare REIT by 9.9% in the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock worth $16,832,000 after buying an additional 81,293 shares during the last quarter. Finally, Tred Avon Family Wealth LLC purchased a new stake in shares of Sabra Healthcare REIT in the third quarter worth about $979,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Up 0.7%

Shares of SBRA opened at $20.49 on Thursday. The company has a market capitalization of $5.17 billion, a price-to-earnings ratio of 32.02, a PEG ratio of 1.62 and a beta of 0.67. The stock’s 50-day moving average price is $20.11 and its 200-day moving average price is $19.18. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a 52 week low of $17.04 and a 52 week high of $21.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). The business had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm’s revenue for the quarter was up 16.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend was Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 187.50%.

Analyst Ratings Changes

A number of brokerages have recently commented on SBRA. Wells Fargo & Company upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. Citigroup upped their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Wall Street Zen downgraded Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. Weiss Ratings upgraded Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Wednesday, March 18th. Finally, UBS Group upped their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $22.00.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.